Trial Design Articles

Mid-Sized CROs Consolidate in Specialized Therapeutic Areas

Sep 10, 2018

By Moe Alsumidaie

Columnist Moe Alsumidae speaks to key Synteract executives on their acquisition of a dermatology CRO to augment its own expertise and grow the specific services necessary for this therapeutic specialty.

Cancer Immunotherapy Biomarkers: Four Trends to Watch

May 29, 2018

By Nina Baluja, M.D.

Here are four trends to watch as researchers continue to make headway in the development of biomarkers for cancer immunotherapy.

How to Minimize Subjectivity in Dermatology Data

Dec 18, 2017

By Darcee Duke Strube

Until more sophisticated measures are created, a combination of investigator training and new imaging methods is the best way to create accurate, reproducible data across sites.

Three Steps to A Successful Combination Product Trial

Nov 28, 2017

By Cynthia Pritchard, PhD

Sponsors can streamline the design and execution of their clinical trials by following this three-step approach.

The Impact of Faster Drug Approvals on Oncology Clinical Trial Design

Sep 13, 2017

By Andrew Zupnick, PhD

Due to a shifting landscape because of faster drug approvals, this article offers strategies for sponsors to design clinical trials.

native1_300x100
lorem ipsum